RENBP and prostate carcinoma: The targets were mainly enriched in the complement and coagulation cascades, IL‐17 signaling pathway, prostate cancer, AGE‐RAGE signaling pathway in diabetic complications, and the HIF‐1 signaling pathway (Figure 2J).